E-LIB Suche - Ergebnisse für: Raab, Marc Steffen

1

Therapeutic Advances Propelled by Deciphering Tumor Biology..:

Lutz, Raphael ; Friedrich, Mirco ; Raab, Marc Steffen..
Cancers. 13 (2021) 16 - p. 4135 , 2021

Link: https://doi.org/10.3390/..

2

Rationale and design of the German-speaking myeloma multice..:

Salwender, Hans ; Bertsch, Uta ; Weisel, Katja...
BMC Cancer. 19 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

3

Prognostic significance of cytogenetic heterogeneity in pat..:

Merz, Maximilian ; Jauch, Anna ; Hielscher, Thomas...
Blood Advances. 2 (2017) 1 - p. 1-9 , 2017

Link: https://doi.org/10.1182/..

4

The Phase 2 Cartitude-2 Trial: Updated Efficacy and Safety ..:

Hillengass, Jens ; Cohen, Adam D. ; Agha, Mounzer...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S36-S37 , 2024

Link: https://doi.org/10.1016/..

5

Autologous Stem Cell Collection after Daratumumab, Bortezom..:

Sauer, Sandra ; Kriegsmann, Katharina ; Nientiedt, Cathleen...
Transfusion Medicine and Hemotherapy. 50 (2023) 5 - p. 371-381 , 2023

Link: https://doi.org/10.1159/..

6

The landscape of small nucleolar RNA expression in multiple..:

Zhao, Duoduo ; Rohde, Christian ; Göllner, Stefanie...
Leukemia. 37 (2023) 12 - p. 2526-2531 , 2023

Link: https://doi.org/10.1038/..

7

Elranatamab in relapsed or refractory multiple myeloma: pha..:

Lesokhin, Alexander M. ; Tomasson, Michael H. ; Arnulf, Bertrand...
Nature Medicine. 29 (2023) 9 - p. 2259-2267 , 2023

Link: https://doi.org/10.1038/..

8

S188: CAR-T CELLS SHAPE THE IMMUNOLOGICAL POTENTIAL OF THE ..:

Frede, Julia ; Poller, Julia ; Shi, Kayleen...
HemaSphere. 7 (2023) S3 - p. e04864bb , 2023

Link: https://doi.org/10.1097/..

9

The pre-existing T cell landscape determines the response t..:

Friedrich, Mirco J. ; Neri, Paola ; Kehl, Niklas...
Cancer Cell. 41 (2023) 4 - p. 711-725.e6 , 2023

Link: https://doi.org/10.1016/..

10

Inhibiting PI3K–AKT–mTOR Signaling in Multiple Myeloma-Asso..:

Heinemann, Luca ; Möllers, Klara Maria ; Ahmed, Helal Mohammed Mohammed...
Frontiers in Oncology. 12 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

11

Poster: MM-183 CARTITUDE-2 Cohort A: Updated Clinical Data ..:

Hillengass, Jens ; Cohen, Adam D ; Delforge, Michel...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S178 , 2022

Link: https://doi.org/10.1016/..

12

OAB-045: Updated clinical data and biological correlative a..:

Cohen, Adam ; Einsele, Hermann ; Delforge, Michel...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S27-S28 , 2022

Link: https://doi.org/10.1016/..

13

MM-183 CARTITUDE-2 Cohort A: Updated Clinical Data and Biol..:

Hillengass, Jens ; Cohen, Adam D ; Delforge, Michel...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S411 , 2022

Link: https://doi.org/10.1016/..

14

IgE type multiple myeloma exhibits hypermutated phenotype a..:

Kehl, Niklas ; Kilian, Michael ; Michel, Julius...
Journal for ImmunoTherapy of Cancer. 10 (2022) 10 - p. e005815 , 2022

Link: https://doi.org/10.1136/..

15

Updated Results of Cartitude-2: Ciltacabtagene Autoleucel (..:

Hillengass, Jens ; Cohen, Adam D. ; Delforge, Michel...
Transplantation and Cellular Therapy. 28 (2022) 3 - p. S62-S63 , 2022

Link: https://doi.org/10.1016/..